Shareholders Equity: The sum of preferred and common equity items.
Oramed Pharmaceuticals Inc. (ORMP) had Shareholders Equity of $199.74M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$9.20M |
|
-- |
|
-- |
|
$5.67M |
|
$-5.67M |
|
$15.47M |
|
$9.80M |
|
$9.80M |
|
$10.01M |
|
$10.01M |
|
$10.01M |
|
$10.01M |
|
$-5.67M |
|
$-5.64M |
|
41.40M |
|
42.42M |
|
$0.24 |
|
$0.15 |
|
| Balance Sheet Financials | |
$133.27M |
|
$0.59M |
|
$97.59M |
|
$230.86M |
|
$19.09M |
|
-- |
|
$12.03M |
|
$31.12M |
|
$199.74M |
|
$199.74M |
|
|
Shareholders Equity |
$199.74M |
39.27M |
|
| Cash Flow Statement Financials | |
$-9.14M |
|
$5.44M |
|
$-4.74M |
|
$54.42M |
|
$45.95M |
|
$-8.47M |
|
$5.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
5.01% |
|
5.01% |
|
4.34% |
|
5.01% |
|
$5.09 |
|
$-0.22 |
|
$-0.22 |
|